Juno Therapeutics (JUNO) to Resume Trading at 8:30AM ET after Clinical Hold Announced

November 23, 2016 8:05 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Juno Therapeutics (NASDAQ: JUNO) set to resume trading at 8:30AM ET after it voluntarily placed on hold the Phase II clinical trial of JCAR015

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk, Trading Halts

Add Your Comment